Company Filing History:
Years Active: 2004
Title: Emmanuelle Trannoy: Innovating Vaccine Delivery Systems
Introduction
Emmanuelle Trannoy, an accomplished inventor based in Lyons, France, has made a significant contribution to the field of vaccine development. With a keen focus on enhancing vaccine efficacy, she has been involved in innovative research, particularly in the development of adjuvants for vaccine compositions.
Latest Patents
Trannoy holds a patent for an adjuvant for a vaccine composition. This invention features an amphipathic compound that includes a sterol-derived lipophilic grouping bonded to a cationic grouping. The patented adjuvant is designed to improve the delivery of vaccine compositions, with specific embodiments utilizing a cholesterol derivative for the lipophilic grouping and a quaternary ammonium or protonatable amine for the cationic grouping. The patent also encompasses vaccine compositions containing one or more antigens along with the described amphipathic compounds.
Career Highlights
Emmanuelle Trannoy currently works at Aventis Pasteur S.A., a prominent entity in the pharmaceutical industry dedicated to vaccine research and development. Her work has been pivotal in advancing methods for effective vaccine delivery and enhancing immunogenic responses.
Collaborations
Throughout her career, Trannoy has collaborated with several esteemed colleagues, including Jean Haensler and Jorge Ronco. These collaborations have facilitated innovative approaches and shared insights that contribute to the potential breakthroughs in vaccine technology.
Conclusion
Emmanuelle Trannoy's contributions to vaccine development through her innovative patent reflect her dedication to improving public health. Her work at Aventis Pasteur S.A. continues to influence advancements in immunization strategies, paving the way for future innovations in the biomedical field. Through teamwork and creative thinking, she exemplifies the impact that inventors can have in tackling global health challenges.